Capstone Investment Advisors
AGIO icon

Capstone Investment Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Capstone Investment Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$341K Buy
+9,196
New +$279K ﹤0.01% 1397
2026
Q1 		– Sell
-10,355
Closed -$282K – 1564
2025
Q4 		$282K Buy
+10,355
New +$363K ﹤0.01% 1380
2017
Q1 		– Sell
-5,200
Closed -$216K – 848
2016
Q4 		$216K Buy
+5,200
New +$273K 0.01% 805

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Capstone Investment Advisors's AGIO Position: Q2 2026 in Review

Capstone Investment Advisors opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2026: 9,196 shares worth $341K. The stake represents ﹤0.01% of the portfolio and ranks #1397 among its holdings. This is a return to the name: Capstone Investment Advisors previously reported a position in AGIO as recently as Q4 2025.

Capstone Investment Advisors first reported a position in AGIO in Q4 2016 and has held it in 3 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Capstone Investment Advisors held 9,196 shares of Agios Pharmaceuticals worth $341K as of Q2 2026.
  • Agios Pharmaceuticals was a new Capstone Investment Advisors position in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #1397 holding.
  • Capstone Investment Advisors first reported a position in Agios Pharmaceuticals in Q4 2016 and has held it in 3 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.